World Health Organisation gives CBD the Green Light.
“CBD has no adverse health outcomes…
…And is good for several conditions.”
– World Health Organisation

We’ve known all along, but it always helps when renowned experts confirm the facts. A World Health Organisation (W.H.O.) report has found no adverse health outcomes, and several medical applications for cannabidiol (CBD), the non-psychoactive ingredient in cannabis.

After months of clinical trials, the organisation’s Expert Committee on Drug Dependence (ECDD) confirmed that, “in humans, CBD exhibits no effects indicative of any abuse or dependence potential.”

Researchers at the global U.N agency went on to affirm that CBD has “been demonstrated as an effective treatment for epilepsy” in adults, children, and even animals, and that there's “preliminary evidence” that CBD could be useful in treating Alzheimer’s disease, cancer, psychosis, Parkinson's disease, and other serious conditions.


The W.H.O. team also confirmed that unlike THC, people aren't getting high off CBD. “To date, there is no evidence of recreational use of CBD or any public health-related problems associated with the use of pure CBD”. In fact, evidence suggests that CBD mitigates the effects of THC - whether it’s elation or anxiety.

Trent Scanlen, Managing Director, Truth Naturals, said “This is great news. The recent focus by reputable organisations such as WHO and Oxford University is helping us share the successes of thousands of customers in the UK. We support further regulation and research to ensure that more people can understand how organic plants can help improve their lives.”

The logical argument for further investigation into a product with such widespread anecdotal evidence of efficacy is hard to continue to deny. Especially when you also consider the wealth of clinical research by reputable institutions, which show CBD to be an effective treatment for chronic pain, PTSD, anxiety, and many other ailments. The W.H.O. recognise this, and their report recommends that CBD ceases to be a scheduled drug.